News archive for Brenk lab
Another paper from the Brenk group published.
Ludvik has joined the lab as PhD student in November. Welcome and good luck with your project!
The Nor-Openscreen application for this year's infrastructure call scored the highest possible marks in all categories! To quote from the reviewer comments: "This is an excellent proposal to enlarge and update existing infrastructure and services in chemical biology in Norway". Despite the very favorable evaluation, the proposal was not funded. This means, there will unfortunately be no new... Read more
Our new paper on entangling selectivity determining features and on how to use this knowledge to design selective ligands has been published in J Med Chem!
Together with Nathalie Reuter and Bengt-Erik Haug from the Chemistry Department and Alexander Lundervold from the H酶gskulen p氓 Vestlandet (HVL) we got funding for the project 芦Towards better computational approaches and responsible innovation strategies in early drug discovery: application to antibiotics and COPD禄 under the Centre for Digital Life umbrella. In this project, we are aiming toward... Read more
Our EXPLORE network application aiming at targeting the TPP riboswitch for hit discovery for new antibiotics will receive funding from JPI-AMR! Other partners in the network are Daniel Lafontaine (Universit茅 de Sherbrooke, Canada), Matthias Mack (Mannheim University of Applied Sciences, Germany), Petr Bartunek (CZ-OPENSCREEN, Czech Republic), Bengt Erik Haug (University of Bergen Norway) and... Read more
Researcher's Grand Prix-cadidate Illimar Hugo Rekand is working to keep us healthy. He is investigating new opportunities for making new medicines in a world where antibiotic resistance is an increasing challenge.
A recording of Ruth's presentation of riboswitch ligand design at the Digital Life 2018 conference.
Our research about development of riboswitch ligands was chosen as partner project for Digital Life Norway.
About state-of the art of riboswitch ligand design and future perspectives.
A webinar about structure-based design of riboswitch and kinase ligands.
The Brenk lab will receive funding from NFR for developing future antibiotics acting via riboswitch binding. This project will fund two postdoc positions for three years, one in the lab of Bengt Erik Haug (Department of Chemistry) and one in the Brenk group. We are looking forward to continuing an exiting research project!
Pages
- April 2025 (1)
- August 2024 (1)
- May 2024 (1)
- February 2024 (1)
- January 2024 (1)
- July 2023 (1)
- March 2023 (1)
- December 2022 (2)
- April 2022 (1)
- March 2022 (1)
- August 2021 (1)
- June 2021 (1)
- May 2021 (1)
- January 2021 (1)
- March 2020 (2)
- February 2020 (2)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- December 2018 (1)
- October 2018 (1)
- September 2018 (1)
- April 2018 (1)
- November 2017 (1)
- October 2017 (1)
- December 2016 (2)
- September 2016 (1)
- May 2016 (2)